Back to Atlas
BSemi-durableStandard research/education caution
CMP-0191
Investigational/compounded in some markets
Enclomiphene
Endocrine / HPG-axis
Testosterone-axis recovery and fertility-preserving hypogonadism positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SERM isomer
- Primary mechanism
- Trans-clomiphene ER antagonism increases LH/FSH signaling
- Primary market use
- Male endocrine / fertility
Pharmacology
- Molecular weight (Da)
- 405.96
- Oral bioavailability
- Oral
- Half-life
- ~10 h reported; variable by formulation
- Route tags
- Route-dependent / verify
- Evidence level
- Human/Clinical
- Clinical status
- Investigational/compounded in some markets
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Higher value than mixed clomiphene conceptually due less estrogenic zuclomiphene exposure; regulatory status limits use